|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.4 USD | -1.10% |
|
+36.02% | +2.47% |
| 07/05 | Bioventus Inc. Revises Earnings Guidance for the Full-Year 2024 | CI |
| 07/05 | Transcript : Bioventus Inc., Q1 2024 Earnings Call, May 07, 2024 |
Bioventus Inc. reported earnings results for the fourth quarter ended December 31, 2023. For the fourth quarter, the company reported sales was USD 135.42 million compared to USD 125.83 million a year ago. Net loss was USD 6.1 million compared to USD 31.93 million a year ago.
Basic loss per share from continuing operations was USD 0.1 compared to USD 0.4 a year ago. Basic loss per share was USD 0.1 compared to USD 0.52 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +2.47% | 345M | |
| +73.46% | 12.41B | |
| -15.61% | 8.23B | |
| +3.88% | 6.46B | |
| +14.69% | 5.5B | |
| -5.53% | 5.33B | |
| +42.58% | 5.1B | |
| -32.61% | 2.54B | |
| +10.80% | 1.99B | |
| -0.74% | 1.99B |
BIOVENTUS INC. 